Name | Description | Funding Type | Funded Company | Funding Round Amount (USD) | Investment | Funding Round Date | ||
---|---|---|---|---|---|---|---|---|
The financing round included previously announced investments by Kreditanstalt für Wiederaufbau (KfW) with USD 343 million, and GSK with USD 171 million, as well as additional new equity from existing and new investors with approximately USD 126 million for a total of USD 640 million. | 640,000,000 | Funding Round Investor Funding Round Investor | ||||||
CureVac raised a Series F round for 29,500,000 USD in November, 2015. | 29,500,000 | Investor Investor | November 3, 2015 | |||||
35,250,000 | Investor | May 10, 2010 | ||||||
CureVac raised a Series F round for 119,633,000 USD in November, 2015. | 119,633,000 | Investor Investor Investor Investor | November 3, 2015 | |||||
CureVac raised a Series E round for 76,000,000 USD in March, 2015. | 76,000,000 | Investor | March 5, 2015 | |||||
CureVac raised a Series B round for 26,675,000 USD in January, 2006. | 26,675,000 | Investor Investor | January 18, 2006 | |||||
CureVac raised a Venture round for 450,000,000 USD in February, 2021. | 450,000,000 | February 2, 2021 | ||||||
CureVac raised a Grant (money) for 306,000,000 USD in September, 2020. | 306,000,000 | September 15, 2020 | ||||||
CureVac raised a Series D round for 104,432,000 USD in September, 2012. | 104,432,000 | Investor | September 18, 2012 |